Home/Pipeline/GEMMA Project (Multi-omics Study)

GEMMA Project (Multi-omics Study)

Multi-center Genomic Research

ResearchActive

Key Facts

Indication
Multi-center Genomic Research
Phase
Research
Status
Active
Company

About Euformatics

Euformatics is a Helsinki-based software company providing an AI-powered, kit-agnostic platform for analyzing clinical next-generation sequencing (NGS) data. Its core offering, the Genomics Hub, enables labs to process raw NGS data into clinical reports, with a strong emphasis on data quality control, regulatory compliance, and workflow automation. The company partners with leading global healthcare and research institutions and is positioned to capitalize on the rapidly expanding clinical NGS market, which is driven by falling sequencing costs and the growth of precision medicine.

View full company profile